MSB 3.46% 97.3¢ mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-64

  1. 495 Posts.
    lightbulb Created with Sketch. 27
    I sure hope we dont get 1200 sufferring from COVID -19 to test on in New York or indeed within USA. That would be diabolical as that would mean an exponential number of people would be sufferring from this disease and indeed ARDS.

    Make no mistake, this needs to be manufactured now as part of a suite of cures and should be made available in all countries. USA and Australia have a humanitarian obligation to see this through...people are suffering and if MSB has a cure for this - then Govts must act now to pave the way.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
97.3¢
Change
0.033(3.46%)
Mkt cap ! $1.084B
Open High Low Value Volume
94.0¢ 97.5¢ 92.0¢ $1.764M 1.856M

Buyers (Bids)

No. Vol. Price($)
22 95772 97.0¢
 

Sellers (Offers)

Price($) Vol. No.
97.5¢ 135728 17
View Market Depth
Last trade - 12.05pm 03/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.